The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives? In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years. “Five years after … Read more
WASHINGTON — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition. Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and … Read more
Jumping into London’s River Thames has been the customary celebration for members of the winning crew in the Boat Race, the nearly 200-year-old rowing contest between storied English universities Oxford and Cambridge. Now it comes with a health warning. Testing by the River Action campaign group found high levels of E.coli along a stretch of … Read more
Jumping into London’s River Thames has been the customary celebration for members of the winning crew in the Boat Race, the nearly 200-year-old rowing contest between storied English universities Oxford and Cambridge. Now it comes with a health warning. Testing by the River Action campaign group found high levels of E.coli along a stretch of … Read more
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths. The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the … Read more
WASHINGTON — The maker of a much-debated drug for Lou Gehrig’s disease said Friday its therapy failed to help patients in a large follow-up study, but stopped short of committing to follow through on a prior pledge to pull the drug from the U.S. market. The Food and Drug Administration approved Amylyx Pharmaceuticals’ Relyvrio in … Read more
WASHINGTON — WASHINGTON (AP) — Jill Biden on Wednesday was announcing $100 million in federal funding for research and development into women’s health as part of a new White House initiative that she is heading up. The funding is the first major deliverable of the White House Initiative on Women’s Health Research, which was announced … Read more
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday. Xolair, the brand name for the drug omalizumab, became the first medication approved to reduce allergic reactions caused by accidental exposure to food triggers. Patients as young as … Read more
LONDON — In British history, the secrecy of the monarch’s health has always reigned supreme. Buckingham Palace’s disclosure that King Charles III has been diagnosed with cancer shattered that longstanding tradition. On the heels of the shock and well-wishing that followed the official statement Monday came the surprise that the palace had announced anything at … Read more
LONDON — In British history, the secrecy of the monarch’s health has always reigned supreme. Buckingham Palace’s disclosure that King Charles III has been diagnosed with cancer shattered that longstanding tradition. On the heels of the shock and well-wishing that followed the official statement Monday came the surprise that the palace had announced anything at … Read more
